Twin Eagle Trade and Makland Pharmaceuticals Launch Global Pharma Alliance to Transform Healthcare Access in West Africa.
PHILADELPHIA – Sept. 8, 2025 – PRLog — Twin Eagle Trade and Makland Pharmaceuticals Launch Global Pharma Alliance to Transform Healthcare Access in West Africa
Structured by 3eye Worldwide
Accra, Ghana / Philadelphia, USA – September 8, 2025
– Twin Eagle Trade (USA) and Makland Pharmaceuticals (Ghana), in collaboration with 3eye Worldwide, proudly announce the launch of the Global Pharma Alliance, a groundbreaking joint venture dedicated to expanding access to essential medicines and strengthening healthcare delivery across Ghana and West Africa.
The Global Pharma Alliance combines the pharmaceutical sourcing and trade expertise of the United States with global distribution networks and Ghana’s regulatory and healthcare infrastructure. Together, these strengths create an integrated system that delivers safe, affordable, and reliable medicines through every major access point in the healthcare chain, from urban centers and rural villages to hospitals, clinics, pharmacies, community health posts, and even telehealth platforms that connect patients directly to care. By aligning import logistics, licensed warehousing, and telehealth-enabled prescription fulfillment, the initiative ensures that children, families, and those managing chronic conditions can access vital treatments quickly and consistently.
At the heart of the venture is a Ghana-based LLC that will import quality-assured U.S.-manufactured medicines through fully compliant supply chains. The alliance will integrate with Ghanaian telehealth platforms to provide same-day or next-day prescription delivery directly to patients’ homes or health points. This innovative model not only improves adherence to treatment plans but also creates new employment opportunities by training a local health logistics workforce, strengthening community-level resilience.
“This partnership is not just about supply chains, it’s about saving lives,” said Steven Brown, CEO of 3eye Worldwide. “Healthcare access is not a privilege; it is a right. With this alliance, we’re building bridges between global innovation and local need, ensuring no child or family is left behind.”
Nana Kwesi Atomu II, Founding Member of Twin Eagle Trade and Atomu Africa Development Services, emphasized the cultural and social significance of the initiative: “This alliance is more than a business venture. It is a promise to our people. By connecting Ghana with global resources, we are creating a future where every family, from the most remote village to the busiest city, can depend on access to essential medicines. This is a milestone not just for healthcare, but for dignity, equity, and progress in West Africa.”
Pilot operations will launch in Ghana, with expansion planned across West Africa as the model scales. The Global Pharma Alliance invites collaboration with global health organizations, impact investors, and pharmaceutical innovators who share the vision of making healthcare access equitable, affordable, and sustainable for all.
About Twin Eagle Trade, LLC
Twin Eagle Trade is a Delaware-based global trade and development company, connecting the United States with emerging markets in Africa through sustainable import/export ventures spanning agriculture, pharmaceuticals, and consumer goods.
About Makland Pharmaceuticals
Makland Pharmaceuticals is a licensed Ghanaian pharmaceutical company committed to sourcing, registering, and distributing essential medicines across Ghana and West Africa.
About Atomu Africa Development Services
Atomu Africa Development Services is a Ghana-based organization dedicated to promoting economic growth, enhancing healthcare access, and advancing infrastructure development across Africa. With a strong focus on building sustainable partnerships, the company works to bridge local needs with global opportunities.
About 3eye Worldwide
3eye Worldwide is a global data-driven consumer insights and strategy firm operating in over 70 countries. The company specializes in building innovative partnerships that bridge international markets and deliver social impact at scale.
